Group items tagged

Avoid up to 9% penalty and earn up to 5% incentives with successful MIPS data submission. P3Care, being one of the leading MIPS Qualified Registries, is your partner to decode high points.

Join us for the prestigious Pharmacy Business Awards 2023, celebrating excellence in community pharmacy. Attend the glittering ceremony in London and witness industry leaders, officials, and ministers. Submit your entry now and showcase the unique services of community pharmacy. Nomination deadline: July 7th, 2023.

Capitalising on strong demand for its obesity therapies, Novo Nordisk's growing appetite for deals has fuelled a bet on a U.S. gene-editing company called Life Edit Therapeutics. The Danish drugmaker's collaboration with Durham, North Carolina-based Life Edit Therapeutics - owned by ElevateBio, a cell and gene therapy company in Waltham - is focused on up to seven programs for rare genetic disorders as well as cardiometabolic diseases. At the heart of the tie-up is Life Edit's technology, called base editing, which is designed to make precise changes to the human genome by tweaking one base - or letter - into a different one without affecting other letters. Single-letter mistakes, called point mutations, can give rise to genetic diseases.

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document published by Nuffield Trust and The King's Fund has revealed. It says community pharmacies in England must adapt to changing population needs amidst unprecedented health and care challenges. Commissioned by Community Pharmacy England, the report titled 'A Vision for Community Pharmacy', published on Sept. 19, is a result of almost a year of research and extensive consultation with the sector and wider stakeholders, advocating for community pharmacy. The think tanks detail a shift in the community pharmacy sector, highlighting how pharmacies can contribute to crucial policy objectives regarding population health, prevention, and the increasing demand in primary care. "The health and care needs of the population are evolving, and pharmacies in England, like all components of the health and care system, must adjust to address these changes," said Helen Buckingham, Director of Strategy at Nuffield Trust.

Being the popular form of ART, In-vitro fertilization is a treatment that stands out to combat the infertility challenges when all other treatments fail.

The National Health Service (NHS) retention programme has benefitted 23 NHS Trusts since it launched in April 2022, with thousands fewer staff leaving frontline roles. NHS data showed that 14,000 fewer staff left the service in the 12 months up to August 2023 (108,890) compared to 122,970 the year before. In a statement released on Thursday, the NHS England said it is expanding the pilot programme across the country to benefit 42 more NHS trusts. The programme is part of the NHS Long Term Workforce Plan ambition to retain up to 128,000 more staff over the next 15 years in addition to training record numbers of doctors, nurses and other healthcare professionals. Under this new initiative, NHS staff are being offered extra flexibility with working hours, clinical 'support squads' have been introduced to help menopausal women at work, and HR 'stay advocates' are designated to identify ways to keep staff on the brink of leaving.

Bestway Healthcare has appointed Jeremy Meader as its new chief wholesale officer, following the retirement of Anup Sodha. Meader would join the company in mid-November but is expected to officially assume his responsibilities from January 2, 2024. He will lead Lexon, Bestway Medhub, Wardle's, Knights Fragrances, PI & Specials manufacturing and the wholesale supply chain. Sodha, who co-founded the business 25 years ago, will continue to lead the company's wholesale business unit until 31 December 2023. Commenting on his retirement, Sodhi said: "I am proud of what we achieved at Lexon, it has been a team effort and I am grateful to everyone who has helped as we built a strong wholesale business.

The Digital Medicines Transformation Portfolio (DMTP) was able to deliver the electronic prescription service (EPS) in Wales - just 20 months after starting the project - with support from key partners in the NHS and industry. Patients in Rhyl were the first to benefit from the new service, which allows GPs to send prescriptions electronically to the patient's choice of community pharmacy, without the need for a paper form. The new EPS service is currently in a live testing phase, with a phased roll out across Wales expected from January 2024. DMTP, which is hosted by Digital Health and Care Wales (DHCW) has worked closely with NHS England, who provided the core EPS platform that has been developed for use in Wales. NHS Wales Shared Services Partnership has also made a major contribution in the project, incorporating digital reimbursement to pharmacies and putting security measures in place.

Mentoplasty, often known as "chin surgery," is a surgical technique to restructure the chin using implant enhancement or bone reduction. It is often suggested to people who are either born with a too-large or too-small chin or have damaged the shape due to an accident. The surgery can provide a more balanced and symmetrical chin-to-face ratio. For a successful chin surgery in India, consult Dr. Shilpi Bhadani at SB Aesthetics.

يقوم أفضل جراحي زراعة الكلى في الهند بإجراء عمليات زرع في المستشفيات المشهورة عالميًا والمجهزة جيدًا والمتفوقة تقنيًا.

Les meilleurs chirurgiens de greffe de rein en Inde effectuent des greffes dans des hôpitaux de renommée mondiale, bien équipés et technologiquement supérieurs.

In a recent report released by the Company Chemists' Association (CCA), data from the NHS Pharmacy First service indicates a substantial uptake and positive impact on patient care just two months after its launch. The CCA's findings shed light on the service's efficacy in meeting patient needs and its potential to alleviate pressure on General Practices (GPs) within the NHS. According to the report, over 90,000 Pharmacy First consultations were conducted solely by CCA members within the initial two-month period. Impressively, 88 per cent of these consultations, totaling 81,627, were deemed eligible for NHS-funded care indicating a significant demand for the service among patients. In the first month, the data revealed that more than 90 per cent of eligible patients received necessary care directly through Pharmacy First, bypassing the need for further referral.